|
|
|
You can get e-magazine links on WhatsApp. Click here
|
|
|
|
|
|
ScaleUp Bio announces initial customers from USA, Australia & Asia
|
|
Wednesday, 01 November, 2023, 08 : 00 AM [IST]
|
|
Singapore
|
ScaleUp Bio, a pioneering, Singapore-based, CDMO provider of submerged microbial precision fermentation facilities, expertise and services, announced an initial list of customers, underscoring strong global interest in the company’s unique value proposition: Collaboration agreement with Australia’s Nourish Ingredients, to support its Asian growth strategy; Signed letters of Intent with USA’s C16 Biosciences, Malaysia-based Ultimeat, and Singapore’s own Allium Bio to explore development of sustainable ingredients for the Asian marketplace
Nourish Ingredients, C16 Biosciences, Ultimeat, and Allium Bio – amongst other prospective customers – each leverage submerged microbial and precision fermentation to develop sustainably produced ingredients for novel foods. The company is playing a vital role in providing these innovators in the food tech space with a bench-to-market pipeline, aiding them in scaling up to pilot-scale commercial production, breaking into Asian markets and beyond.
Francisco Codoñer, CEO, ScaleUp Bio, said, "We are truly excited to announce our first group of customer partners who are joining us in building the future of food through microbial precision fermentation. These companies recognise the significant growth opportunities for novel foods across Asia and understand the truly unique advantages ScaleUp Bio offers, enabling them to achieve their strategic business objectives and together, empowering the next food revolution.”
The company was established in the third quarter of 2022, as a joint venture company of global nutrition leader ADM and Nurasa, a wholly owned company of Singapore’s global investment giant, Temasek. Charged to fulfil critical scaling-up gaps faced by global food tech innovators, ScaleUp Bio delivers a unique mix of facilities, expertise, experience, and essential services through a clear, Contract Development Manufacturing Organization (CDMO), fee-for-service business model. Both aspiring start-ups and established companies seeking to develop novel food innovations from bench to market, can avail of ScaleUp Bio’s offerings.
Collaboration agreement with Australia’s Nourish Ingredients
The company is collaborating with its first customer partner, Australia’s Nourish Ingredients, to bring sustainable fermentation-based speciality fats to an Asian audience. ScaleUp Bio is uniquely positioned via its specialised expertise to deliver assistance, insights, and regulatory advice for companies to succeed in Asia.
The brand was founded in Australia in 2019, to create animalic fats that make plant proteins delicious. With a rise in consumer interest and market take-up for plant-based proteins, most manufacturers relied on palm and coconut oils to provide fats, which fail to deliver the animalic taste consumers want.
Nourish Ingredients has chosen Singapore as a strategic Asia Pacific hub for scaling production of its animal-free breakthrough fats, designed to provide global food and ingredient makers an ingredient that cooks, smells and tastes just like traditional meat for consumers. The company’s partnership with ScaleUp Bio will support 10,000 litres of fermentation capacity as well as 100 litres of thermal processing, to successfully scale production of speciality fats and unlock flavour for the next generation of plant-based proteins.
Dr James Petrie, CEO, Nourish Ingredients, said, “Fats are an essential element that give meat and dairy their unique taste and texture, however, many plant proteins are laden with overprocessed ingredients or plant oils that fail to deliver on taste. Nourish Ingredients recreates the most potent, animalic fats sourced in nature without the animal, to unlock the flavour and experience consumers want and expect from plant-based products. Working with ScaleUp Bio will give us invaluable access to technical expertise and food-grade facilities, to help scale our fats. We look forward to deepening and expanding our partnership in the coming months.”
|
|
|
|
|
|
|
|
|
|